| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 6 |
| 1 | MERCAPTOPURINE | 6 |
| 2 | FLUOROURACIL | 3 |
| 3 | FLUOROURACIL CREAM, 0.5% | 3 |
| 4 | OXALIPLATIN | 3 |
| 5 | ANASTROZOLE | 2 |
| 6 | ANASTROZOLE TABLETS | 2 |
| 7 | GLIPIZIDE | 2 |
| 8 | RANITIDINE | 2 |
| 9 | ABEMACICLIB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | 1 | 0.0081 |
| 1 | NISOLDIPINE | 1 | 0.0008 |
| 2 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 3 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 1 | 0.0004 |
| 4 | MERCAPTOPURINE | 6 | 0.0003 |
| 5 | FAMOTITINE | 1 | 0.0003 |
| 6 | CYPROHEPTADINE HYDROCHLORIDE | 1 | 0.0002 |
| 7 | PALONOSETRON HYDROCHLORIDE | 1 | 0.0002 |
| 8 | CALCIUM CARBONATE, SIMETHICONE | 1 | 0.0002 |
| 9 | EPIRUBICIN HYDROCHLORIDE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 6 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 3 |
| 2 | Platinum-based Drug [EPC] | 3 |
| 3 | Aromatase Inhibitor [EPC] | 2 |
| 4 | GLP-1 Receptor Agonist [EPC] | 2 |
| 5 | Osmotic Laxative [EPC] | 2 |
| 6 | Sulfonylurea [EPC] | 2 |
| 7 | Alkylating Drug [EPC] | 1 |
| 8 | Amide Local Anesthetic [EPC] | 1 |
| 9 | Antiarrhythmic [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 1 | Anticholinergic [EPC] | 1 | 0.0001 |
| 2 | Typical Antipsychotic [EPC] | 1 | 0.0000 |
| 3 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 4 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 5 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 7 | Aromatase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Sulfonylurea [EPC] | 2 | 0.0000 |
| 9 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |